Literature DB >> 1414680

RP 54745, a potential antirheumatic compound. I. Inhibitor of macrophage stimulation and interleukin-1 production.

F Folliard1, A Bousseau, B Terlain.   

Abstract

RP 54745 is an amino-dithiole-one compound found to be active at micromolar concentration on the metabolism of stimulated macrophages, for example, the hexose monophosphate pathway (HMP) and the exocytosis of lysosomal enzymes. LPS-induced interleukin-1 (IL-1) production by murine peritoneal macrophages was also diminished by this compound in vitro as well as in vivo. This effect was confirmed at the mRNA level; at the concentration of 3 x 10(-6) M, the IL-1 alpha and beta mRNA signals were inhibited, whereas the TNF alpha mRNA signal was only slightly lessened. These observations were confirmed in vivo, with a dose of RP 54745 of 25 mg kg-1. These results led us to consider that RP 54745 might influence certain cells and cytokines implicated in the regulation of the immune system, the disfunctioning of which can lead to inflammatory disorders or autoimmune pathologies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414680     DOI: 10.1007/bf01991239

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  21 in total

1.  3-(5-Alkyl-4-hydroxy-3-methoxy-1-naphthalenyl)-2-methyl-2-propenoic acids as orally active inhibitors of IL-1 generation.

Authors:  M Tanaka; K Chiba; M Okita; T Kaneko; K Tagami; S Hibi; Y Okamoto; H Shirota; M Goto; H Sakurai
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

Review 2.  How important are T cells in chronic rheumatoid synovitis?

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1990-06

3.  Inhibition of interleukin-1 release by IX 207-887.

Authors:  J Schnyder; P Bollinger; T Payne
Journal:  Agents Actions       Date:  1990-06

4.  Dexamethasone selectively regulates LPS-inducible gene expression in murine peritoneal macrophages.

Authors:  S Narumi; T A Hamilton
Journal:  Immunopharmacology       Date:  1990 Mar-Apr

Review 5.  Cytokine assays: role in evaluation of the pathogenesis of autoimmunity.

Authors:  M Feldmann; F M Brennan; D Chantry; C Haworth; M Turner; P Katsikis; M Londei; E Abney; G Buchan; K Barrett
Journal:  Immunol Rev       Date:  1991-02       Impact factor: 12.988

Review 6.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

7.  Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; L D Butler
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes.

Authors:  D M Chang; P Baptiste; P H Schur
Journal:  J Rheumatol       Date:  1990-09       Impact factor: 4.666

9.  Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.

Authors:  J C Lee; D E Griswold; B Votta; N Hanna
Journal:  Int J Immunopharmacol       Date:  1988

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  3 in total

1.  Measurement and drug induced modulation of interleukin-1 level during zymosan peritonitis in mice.

Authors:  K Török; K Németh; F Erdö; P Arányi; J I Székely
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

Review 2.  Role of hsp70 in cytokine production.

Authors:  T J Hall
Journal:  Experientia       Date:  1994-11-30

3.  RP 54745, a potential antirheumatic compound. II. In vivo properties in different animal models.

Authors:  F Folliard; A Bousseau; B Terlain
Journal:  Agents Actions       Date:  1992-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.